2002
DOI: 10.1016/s0015-0282(02)03320-4
|View full text |Cite
|
Sign up to set email alerts
|

Elevated soluble Fas ligand levels may suggest a role for apoptosis in women with endometriosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
38
0
1

Year Published

2004
2004
2016
2016

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(39 citation statements)
references
References 29 publications
0
38
0
1
Order By: Relevance
“…Our findings suggest that low levels of sFas may be associated with increase of apoptotic activity in IVF patients with different causes of infertility. In a study about serum sFasL levels in women with endometriosis, elevated sFasL levels were found in patients compare with fertile women without endometriosis [22]. They think that women with endometriosis is susceptible to apoptosis more thanwomen without disease.…”
Section: Discussionmentioning
confidence: 97%
“…Our findings suggest that low levels of sFas may be associated with increase of apoptotic activity in IVF patients with different causes of infertility. In a study about serum sFasL levels in women with endometriosis, elevated sFasL levels were found in patients compare with fertile women without endometriosis [22]. They think that women with endometriosis is susceptible to apoptosis more thanwomen without disease.…”
Section: Discussionmentioning
confidence: 97%
“…Substantial evidence links NFKB to antiapoptotic and proapoptotic effects, through the BCL2 family and the FAS/FASLG complex (Lee et al 1999, Pahl 1999, Wang et al 1999, Harada et al 2004. In ectopic and/or eutopic endometria from endometriosis patients, endometrial cell viability is mainly controlled by the overexpression of BCL2 and a decreased expression of BAX and FAS molecules (Meresman et al 2000, Garcia-Velasco et al 2002, Johnson et al 2005, effects that may allow cell survival in ectopic sites. Although the reduced function of the NFKB system observed in our results does not explain the mechanism by which apoptosis is reduced in eutopic endometrium from endometriosis patients, in other pathologies such as adenomyosis, defined as the presence of ectopic endometrium within the myometrium, the decrease in apoptosis was regulated by mediators other than BCL2 (Yang et al 2007), while in breast cancer and in B-cell leukaemia an association between enhanced expression of BCL2 and NFKB2, other NFKB heterodimers, was shown (Viatour et al 2003).…”
Section: Discussionmentioning
confidence: 99%
“…Apoptosis of eutopic and ectopic endometrial tissues may be less relied on FAS expression (Agic et al 2009). A study by Garcia-Velasco et al (2002) showed that elevated apoptosis of FAS-expressing immune cells in the peritoneal cavity of women with advanced endometriosis is attributed to high levels of soluble FASLG, impairing the removal of ectopic endometrial cells. This suggests a role for apoptotic deregulation in the pathophysiology of endometriosis.…”
Section: R202 L Pirdel and M Pirdelmentioning
confidence: 99%